Best EDC for CNS and neuroscience trials

In many therapeutic areas the primary endpoint is a lab value or an event. In central nervous system trials it is often a score: a clinician-rated scale in depression, schizophrenia, Parkinson's or multiple sclerosis, a cognitive battery in dementia, or a seizure or headache diary kept by the participant. These measurements are subjective, vary between raters and are sensitive to timing, so the quality of the data depends on process as much as on software. An EDC that treats a scale as a form with a few fields misses what matters: who scored it, when, under what recall window and whether a blinded rater ever saw something they should not.

That is why selection criteria for CNS differ from a general EDC buying checklist. You are looking for forms that can hold an instrument item by item, an audit trail that attributes every entry to a person, role design that supports blinded and unblinded staff in the same study, participant questionnaires on a phone that land in the same record as site data, and visit windows that make out-of-window assessments visible early. The therapeutic-area depth is covered on our pages for EDC for CNS and neurology trials, EDC for psychiatry trials, Alzheimer's and dementia and Parkinson's disease.

CNS programs also tend to be run by lean biotechs, with a small clinical operations team and a CRO for sites. A system that the sponsor team can build, test and change without a vendor project suits that structure, and a system that locks the sponsor out of its own build does not. Ask who changes forms mid-study and how long a change takes; see protocol amendments without change orders.

Capture is a self-serve platform combining EDC, an eCRF builder, ePRO, eConsent, randomization and safety reporting with one audit trail. A clinician-rated scale is built as a site form with one typed field per item, scheduled across the visit plan, with edit checks and visit windows. The AI study builder can draft visits and forms from a protocol, and nothing is saved without human review. Starting points include the PHQ-9, C-SSRS, MoCA, MMSE, ADAS-Cog and UPDRS template pages, which show the structure of each form.

On licences, be exact. Capture does not supply licensed instruments or their wording and does not verify licences. Licence tracking controls exist on participant questionnaires only; for clinician-rated and site-completed scales the licence stays with your study documents. Nothing is blocked while licence details are missing from a questionnaire, and after a recorded expiry date no new tasks are generated. Plan with your legal and clinical teams who obtains permission for each instrument.

Participants answer diaries on their phone by secure link, with reminders, quiet hours and completion windows, and entries land in the same record as site data; see ePRO software for clinical trials. Blinded roles never receive treatment-arm values, enforced by masked database views, and randomization sits in the same system; see clinical trial platform with randomization. Each audit entry records user, old value, new value and reason for change, which is how you show attribution of a score. The controls are 21 CFR Part 11-aligned, with compliance shared with the sponsor's own validated use. Capture is used for Phase 1, 2 and 3 studies, so a pivotal CNS program is a normal use case.

Capture does not train or certify raters, run central rating or provide licensed scales. If your program depends on independent central review of recorded interviews, or on a vendor that delivers licensed instruments in a controlled way, that sits alongside the EDC, not inside it. It is also not an imaging core lab: if MRI or PET reads are a main data flow with central reading and adjudication, you will need a dedicated imaging system. Likewise a dedicated pharmacovigilance safety database remains a separate category, though adverse events are captured on the eCRF with an SAE workflow.

Finally, if your sponsor or CRO mandates its own EDC, you will use theirs, and if you need a validated CDISC SDTM export from the system itself, check current documentation, because Capture labels templates with SDTM domains rather than claiming a validated transformation. None of these limits is about trial size or phase.

For the general market, see best EDC software in 2026. If your CNS program is run by a small CRO, best EDC for small CROs covers that angle, and teams moving from academic tooling can read how to migrate from REDCap.